Medtech startup Wrig Nanosystems Tuesday launched a first of its kind ultra-convenient haemoglobin measurement device, TrueHb Hemometer, to help eradicate anaemia in the country.
The hemometer is compact, ultra-convenient and a portable device with 99 percent accuracy which has been validated at All India Institute of Medical Science (AIIMS). It is rechargeable and has high precision at a low price.
"Currently, the availability and proximity of blood testing facilities is a challenge, globally. Through our innovations, we intend to empower first point-of-care with miniaturized pocket sized blood testing devices based on bioelectronics disruptive technologies," said Ambar Srivastava, founder and managing director of the startup at the Technical Business Incubator Unit of IIT Delhi.
The device is first of its kind in India and is truly multi-disciplinary.
It has been developed after extensive research in biochemistry, micro-optics, embedded electronics, computational algorithms and automated mass production machine designing.
"We are aspiring to revolutionize the global healthcare paradigm through disruptive innovations," Srivastava added.
Wrig Nanosystems is now building an all-in-one compact device, targeted to tap over 70 percent of pathology lab traffic at the first point-of-care. Such a device can speed up the blood testing investigation process, store EMR data and make healthcare smarter. Such a device will also empower far flung rural areas with reasonable medical services.
Wrig is strategically targeting to tap the $200 billion clinical pathology market through innovation and rapid commercial expansion.